Navasa M - Search Results

1

Indocyanine-green: infusion rate and reactions.

Ruiz del Arbol L, García-Pagán JC, Feu F, Navasa M, Bosch J. Ruiz del Arbol L, et al. Among authors: navasa m. Ann Intern Med. 1989 May 15;110(10):844-5. doi: 10.7326/0003-4819-110-10-844_2. Ann Intern Med. 1989. PMID: 2712466 No abstract available.

2

[Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].

Navasa M, García-Pagán JC, Bosch J, Rodés J. Navasa M, et al. Med Clin (Barc). 1992 Feb 29;98(8):290-4. Med Clin (Barc). 1992. PMID: 1560714 Spanish.

3

Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial.

Bosch J, Groszmann RJ, García-Pagán JC, Terés J, García-Tsao G, Navasa M, Mas A, Rodés J. Bosch J, et al. Among authors: navasa m. Hepatology. 1989 Dec;10(6):962-8. doi: 10.1002/hep.1840100612. Hepatology. 1989. PMID: 2511136 Clinical Trial.

4

On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease.

Carreras E, Grañena A, Navasa M, Bruguera M, Marco V, Sierra J, Tassies MD, García-Pagán JC, Martí JM, Bosch J, et al. Carreras E, et al. Among authors: navasa m. Ann Hematol. 1993 Feb;66(2):77-80. doi: 10.1007/BF01695888. Ann Hematol. 1993. PMID: 8448243

5

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: navasa m. J Hepatol. 1990 Sep;11(2):189-95. doi: 10.1016/0168-8278(90)90112-5. J Hepatol. 1990. PMID: 2123914 Clinical Trial.

6

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J. Garcia-Pagán JC, et al. Among authors: navasa m. Hepatology. 1990 Feb;11(2):230-8. doi: 10.1002/hep.1840110212. Hepatology. 1990. PMID: 2307401

7

Lymphocyte beta 2-adrenoceptors and plasma catecholamines in patients with cirrhosis.

García-Pagán JC, Navasa M, Rivera F, Bosch J, Rodés J. García-Pagán JC, et al. Among authors: navasa m. Gastroenterology. 1992 Jun;102(6):2015-23. doi: 10.1016/0016-5085(92)90327-u. Gastroenterology. 1992. PMID: 1316859

8

Evaluation of the portal hypertensive patient.

Bosch J, Pagán JC, Bruix J, Ruiz del Arbol L, Pizcueta MP, Navasa M, Feu F, Bru C, Rodés J. Bosch J, et al. Among authors: navasa m. J Gastroenterol Hepatol. 1989;4 Suppl 1:39-47. J Gastroenterol Hepatol. 1989. PMID: 2519083 Review.

9

Portal hypertension.

Bosch J, Navasa M, Garcia-Pagán JC, DeLacy AM, Rodés J. Bosch J, et al. Among authors: navasa m. Med Clin North Am. 1989 Jul;73(4):931-53. doi: 10.1016/s0025-7125(16)30646-0. Med Clin North Am. 1989. PMID: 2657268 Review.

10

Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis.

Navasa M, Feu F, García-Pagán JC, Jiménez W, Llach J, Rimola A, Bosch J, Rodés J. Navasa M, et al. Hepatology. 1993 Mar;17(3):355-60. Hepatology. 1993. PMID: 8444409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page